Astrologers would say this is the Age of Pisces, while the Chinese zodiac calls it the Year of the Dragon. For health care, it might be a good time to start calling it the "Great Generic Epoch."
Teva Pharmaceutical Industries has named Carlo De Notaristefani as president and CEO of global operations and Aharon "Arik" Yaari as EVP community and institutional affairs, the Israeli drug maker said Thursday.
A district court ruled in favor of Pfizer and Northwestern University in a patent infringement case relating to Lyrica (pregabalin).
Dr. Reddy's Labs has launched a generic version of a popular cholesterol drug.
British drug maker GlaxoSmithKline will acquire development partner Human Genome Sciences for $3.6 billion, GSK said Monday.
The main office of the Food and Drug Administration in charge of regulating generic drugs has appointed a new director, the agency said Friday.
Nearly 200 drugs for mental illnesses are under clinical development or under review by the Food and Drug Administration, the largest lobbying group for the drug industry said Thursday.
Dr. Reddy's has launched a drug designed to prevent and treat osteoporosis.
Mylan is challenging the patent protection on a Pfizer drug for treating depression, following an announcement of a similar challenge by Watson made earlier this week.
Generic drug maker Watson Pharmaceuticals is challenging the patent protection on an antidepressant made by Pfizer, the company said.
The Food and Drug Administration has approved a new indication for a Pfizer drug.
Perrigo on Friday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for lansoprazole capsules in the 15-mg strength.
The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.
GlaxoSmithKline is acquiring the remainder of a privately owned research and development company, GSK said Tuesday.
Novartis' generics division has acquired Fougera Pharmaceuticals, the company said Wednesday.
The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.
Biotech drug maker Amgen is buying a pharmaceutical company based in Turkey, the companies said Wednesday.
Dr. Reddy's Labs has launched a generic version of an Eli Lilly drug used to treat psychiatric disorders, the company said Tuesday.
Watson Pharmaceuticals announced the launch of an authorized generic version of a drug used to lower blood glucose in patients with Type 2 diabetes.
A trade organization representing generic drug manufacturers announced Thursday its latest solution to the problem of drug shortages.
Generic drug maker Watson is challenging the patent protection on a drug used to treat Type 2 diabetes.
Valeant Pharmaceuticals International is acquiring "certain assets" of a drug maker based in Mexico.
Two drug makers have signed a deal to develop an experimental drug for treating two types of cancer.
The Pharmaceutical Research and Manufacturers of America announced Friday the appointment of Eli Lilly chairman, president and CEO John Lechleiter as PhRMA chairman at its annual meeting.
Prasco Labs will market an authorized generic version of a drug used to treat diarrhea caused by a bacterial infection, the company said Wednesday.